CEO SUMMARY: Just four weeks remain before CMS begins collecting private payer clinical laboratory test price data. Many lab industry executives have charged that Medicare officials are not following the language of the PAMA statute or the intent of Congress. At stake are $5.4 billion in Part B fee cuts that CMS plans to introduce. …
Should Labs File Court Challenge To PAMA Price Report Rule? Read More »
To access this post, you must purchase The Dark Report.